Research Study
View Full Study →
A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder.
Citation
Papakostas G., Johe K., Hand H., Drouillard A., Russo P. et al. (2020). A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder.. Molecular psychiatry. DOI: 10.1038/s41380-018-0334-8
Abstract
Abstract not available. See citation for source.
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.